Agios Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $38.6M | $28.6M | $9.9M | $42.1M |
| FY2017 | $-285.2M | $-289.9M | $4.6M | $47.8M |
| FY2018 | $-304.4M | $-311.4M | $7.0M | $73.4M |
| FY2019 | $-370.6M | $-382.7M | $12.0M | $58.1M |
| FY2020 | $-290.8M | $-304.9M | $14.1M | $61.6M |
| FY2021 | $-407.3M | $-413.1M | $5.7M | $53.5M |
| FY2022 | $-309.5M | $-314.4M | $4.9M | $49.3M |
| FY2023 | $-296.1M | $-297.1M | $999.0K | $44.8M |
| FY2024 | $-389.8M | $-391.5M | $1.7M | $42.8M |
| FY2025 | $-373.0M | $-377.3M | $4.3M | $52.6M |